Studying high-risk endometrial cancer with blood and tissue tests
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Planning full surgical treatment for endometrial cancer at Mayo Clinic
- Your cancer has high-risk features, like aggressive cell type or spread beyond the uterus
- Willing to provide blood and tissue samples for research
- Willing to return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at women with low-risk endometrial cancer who had tiny amounts of cancer cells found in their sentinel lymph nodes during surgery. Doctors want to see if it's safe to avoid additional treatments like chemotherapy or radiation.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This trial looks at better ways to predict how aggressive your endometrial cancer is before surgery, so doctors can decide if they need to check your lymph nodes. It may help tailor your treatment to avoid unnecessary procedures.
This study uses advanced genetic testing (next-generation sequencing) to look at the molecular makeup of endometrial cancer or its rare subtype, carcinosarcoma. The goal is to better understand the cancer and possibly guide more personalized treatment.
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
Hear when a new Endometrial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.